During the past decade, Clínica Universitaria Bolivariana conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clínica Universitaria Bolivariana" are "Chronic Cough" (2 trials), "Acute Respiratory Failure" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Seasonal Influenza" (1 trials). Many other conditions were trialed in "Clínica Universitaria Bolivariana" in a lesser frequency.

Most popular intervention types in "Clínica Universitaria Bolivariana" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Gefapixant" (2 trials), "Licensed quadrivalent inactivated seasonal influenza vaccine" (1 trials), "Ustekinumab (approximately 6 mg/kg)" (1 trials) and "Ustekinumab 90 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clínica Universitaria Bolivariana" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clínica Universitaria Bolivariana". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clínica Universitaria Bolivariana, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clínica Universitaria Bolivariana, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".